Comparison · NCT00615550-bda9ced6
Prochieve vs Placebo: Number of Participants With Birth <=32 6/7 Weeks Gestation.
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Prochieve vs Placebo: Number of Participants With Birth <=32 6/7 Weeks Gestation. Trial comparisons, record NCT00615550-bda9ced6. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00615550-bda9ced6
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0894 | 0.0592 | 0.133 | wilson | |
| Risk in group 2 | 0.161 | 0.119 | 0.215 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0721 | -0.134 | -0.0114 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.554 | 0.334 | 0.918 | log | |
| Odds ratio, group 1 over group 2 | 0.51 | 0.287 | 0.904 | log | |
| Number needed to treat, for one fewer participant with the outcome on Prochieve than on Placebo | 13.9 | 7.47 | 88.1 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Prochieve | Progesterone 8% Vaginal Gel | 21 | 235 | OG001 |
| Group 2 | Placebo | placebo vaginal gel | 36 | 223 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Number of Participants With Birth <=32 6/7 Weeks Gestation.
- Description
- Time frame
- 9 to 13 weeks
- Population
- Intent to Treat
Source ClinicalTrials.gov
Trial
- Title
- PREGNANT Short Cervix Trial
- NCT number
- NCT00615550
- Phases
- PHASE3
- Conditions
- Preterm Delivery, Short Cervix, Short Uterine Cervical Length
- Interventions
- progesterone, placebo
- Lead sponsor
- Juniper Pharmaceuticals, Inc.
- Results first posted
- 2012-03-13
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00615550?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00615550-bda9ced6